ERcast: Clinical Perspectives Podcast Preview

Subscription Required

Lit Matters #2: Angiotensin Converting Enzyme Inhibitor Associated Angioedema

Salim Rezaie, MD and Matthieu DeClerck, MD

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

ACE inhibitor angioedema is a bradykinin-mediated airway problem, and predicting who will deteriorate remains difficult. Isolated lip swelling appears lower risk, especially after a longer symptom duration, while tongue swelling and voice change remain the exam findings that should raise concern for impending airway compromise.

ACE Inhibitor Angioedema Risk Stratification

  • Isolated lip swelling: Isolated lip swelling is relatively reassuring in ACE inhibitor angioedema, particularly when symptoms have been present for more than 12 hours, but it is not fully sensitive and cannot by itself rule out later airway intervention.
  • Posterior airway warning signs: Tongue swelling and vocal changes are the bedside findings that deserve the most respect, reflecting more concerning posterior involvement than anterior facial swelling alone.
  • Unreliable routine exam findings: Uvula, floor-of-mouth, and soft-palate swelling did not clearly separate intubated from non-intubated patients in this cohort, underscoring how limited exam-based prediction can be.
  • Timing as a risk clue: Rapid progression over the first 6 hours appears more worrisome, whereas isolated symptoms persisting beyond 12 hours seem lower risk. We get into how that timing changes observation decisions in the episode.
  • Role of nasopharyngoscopy: Nasopharyngoscopy may help uncover occult laryngeal involvement, and prior studies have argued for broader ENT evaluation, though exactly who should be scoped remains unsettled.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

Faculty